Benzinga | Nov 4, 2020 04:07PM EST

Macrogenics Q3 EPS $(0.66) Beats $(0.93) Estimate, Sales $18.25M Beat $15.79M Estimate

Macrogenics (NASDAQ:MGNX) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.93) by 29.03 percent. This is a 27.47 percent increase over losses of $(0.91) per share from the same period last year. The company reported quarterly sales of $18.25 million which beat the analyst consensus estimate of $15.79 million by 15.60 percent. This is a 2.60 percent decrease over sales of $18.74 million the same period last year.